Community Health Systems ...

NYSE: CYH · Real-Time Price · USD
2.79
0.06 (2.20%)
At close: Aug 15, 2025, 12:04 PM

Community Health Systems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
12.65B 12.65B 12.63B 12.55B 12.55B 12.52B 12.49B 12.45B 12.39B 12.21B 12.21B 12.3B 12.39B 12.47B 12.37B 12.25B 12.27B 11.78B
Cost of Revenue
6.4B 7.96B 9.48B 9.48B 9.48B 8.43B 7.41B 7.4B 7.41B 7.35B 7.3B 7.31B 7.33B 7.31B 7.28B 7.31B 7.33B 7.26B
Gross Profit
6.25B 4.69B 3.15B 3.07B 3.07B 4.09B 5.08B 5.05B 4.98B 4.86B 4.91B 5B 5.06B 5.15B 5.08B 4.95B 4.94B 4.51B
Operating Income
869M 595M 542M 591M 969M 977M 956M 857M 888M 761M 821M 1.02B 1.15B 1.35B 1.4B 1.42B 1.36B 1.34B
Interest Income
1M 1M 1M n/a n/a n/a n/a 206M 206M 206M 206M n/a n/a n/a n/a n/a n/a n/a
Pretax Income
150M -238M -283M -154M 232M 222M 206M 338M 441M 303M 350M 246M 330M 519M 500M 668M 662M 606M
Net Income
-192M -487M -515M -398M -98M -123M -133M 235M 284M -4M 77M -160M -7M 325M 231M 364M 365M 429M
Selling & General & Admin
1.59B 1.66B 298M 302M 308M 315M 319M 322M 323M 321M 317M 312M 307M 307M 308M 310M 320M 324M
Research & Development
n/a n/a n/a 80M 80M 80M 80M 85M 85M 85M 85M n/a n/a n/a n/a n/a n/a n/a
Other Expenses
4.63B 3.02B 4.42B 4.21B 3.82B 3.43B 3.39B 3.53B 3.37B 3.37B 3.36B 3.27B 3.25B 3.49B 3.35B 3.2B 3.24B 2.83B
Operating Expenses
6.22B 4.68B 4.72B 4.59B 4.21B 4.17B 4.14B 4.19B 4.04B 4.04B 4.02B 3.93B 3.91B 3.8B 3.66B 3.51B 3.56B 3.15B
Interest Expense
866M 868M 860M 852M 844M 835M 831M 827M 836M 847M 857M 872M 871M 872M 886M 918M 959M 1B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.02B 12.05B 12.08B 11.95B 11.57B 11.56B 11.55B 11.59B 11.45B 11.39B 11.33B 11.24B 11.24B 11.11B 10.94B 10.82B 10.89B 10.41B
Income Tax Expense
188M 94M 80M 95M 178M 192M 190M -38M 13M 175M 172M 291M 231M 85M 131M 170M 180M 68M
Shares Outstanding (Basic)
134M 132.88M 132M 132.38M 132.34M 131.27M 131M 130.7M 130.66M 127.5M 129M 129.14M 129.1M 127.82M 127M 127.08M 127.07M 125.49M
Shares Outstanding (Diluted)
135M 132.88M 132M 132.38M 132.34M 131.27M 132M 130.7M 130.66M 129.69M 130M 129.14M 129.1M 128M 133M 130.89M 130.74M 125.75M
EPS (Basic)
-1.47 -3.68 -3.89 -3.01 -0.76 -0.95 -1.04 1.82 2.19 -0.05 0.58 -1.23 -0.03 2.54 1.80 3.05 3.16 3.73
EPS (Diluted)
-1.49 -3.68 -3.89 -3.01 -0.76 -0.95 -1.03 1.80 2.17 -0.07 0.55 -1.29 -0.11 2.46 1.72 2.95 3.07 3.64
EBITDA
1.48B 1.09B 1.06B 1.17B 1.56B 1.56B 1.54B 1.69B 1.66B 1.53B 1.58B 1.49B 1.72B 1.92B 1.93B 2.13B 2.04B 1.6B
EBIT
1.02B 633M 580M 700M 1.08B 1.06B 1.04B 1.17B 1.13B 993M 1.05B 958M 1.19B 1.39B 1.39B 1.59B 1.62B 1.61B
Depreciation & Amortization
456M 476M 486M 478M 489M 488M 505M 520M 529M 538M 534M 529M 529M 529M 539M 542M 544M 552M